Saidal Group convened an extraordinary session of its Scientific Council on 8 November 2026. The meeting focused on scientific matters connected to the group's current industrial activities and its future strategic orientations within Algeria. Participants reviewed the technical requirements necessary to align the organization's pharmaceutical production with its broader development goals. This event, held on November 8, 2026, served as a platform for the Saidal Group to address the specific scientific issues related to the group's activities and strategic orientations.
Enhancing Internal Scientific Coordination
Saidal Group initiated this meeting to improve consultation and coordination among the members of the Scientific Council. Participants discussed mechanisms to streamline communication channels between departmental researchers and management. Internal workflows for technical evaluation were reviewed to ensure that expertise from various units contributes directly to operational decision-making. By facilitating this dialogue, the organization intends to enhance consultation and coordination among the members of the Scientific Council to foster a more collaborative research environment.
The session represents a component of the broader program by Saidal Group to strengthen scientific thinking across its facilities in Algeria. Management stated that these efforts aim to provide a solid foundation for supporting the organization's strategic development. The council members assessed internal processes to identify how current research projects can better align with long-term industrial objectives. Strengthening the role of the Scientific Council serves as the primary method for integrating technical oversight into the future planning of the group.
This session is part of the group's efforts to strengthen scientific thinking and support its strategic development. By prioritizing the Scientific Council, Saidal Group is formalizing its commitment to integrating advanced research methodologies into its standard operational procedures. The members of the council evaluated the current distribution of research resources to ensure that every facility in Algeria is equipped to meet the technical requirements discussed during the meeting.
The management of Saidal Group emphasized that the outcomes of this extraordinary session will serve as a guiding framework for future industrial projects. By aligning scientific research with the specific strategic orientations identified by the council, the organization aims to maintain its technical standards. The integration of these scientific perspectives is expected to refine the internal decision-making processes, ensuring that management has access to full technical evaluations. The participants focused on the importance of sustaining this coordination to ensure that scientific thinking remains at the core of the organization’s long-term planning. The commitment to these goals reflects the broader strategy of Saidal Group to leverage internal expertise for the advancement of its pharmaceutical production capabilities. As the council continues its work, the focus remains on maintaining the momentum generated during this session to support the overall strategic development of the group.
